Menier's Disease - Bone Density Study

Sponsor
HaEmek Medical Center, Israel (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05322538
Collaborator
(none)
60
2
75

Study Details

Study Description

Brief Summary

Meniere's disease is a progressive and debilitating inner ear disease characterised by vertigo and hearing loss. Several studies have linked Menierws disease with lower bone density and lower vitamin D levels. In the current prospective study definite Meniere's patients will be followed over a period of 2 year, during which repetitive measurements of bone density, vitamin D plasma levels, blood pressure as well as hearing and vestibular tests will be made. Results will be compared to healthy controls.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: vitamin D plasma levels baseline
  • Diagnostic Test: Dual-energy X-ray absorptiometry at baseline
  • Diagnostic Test: cervical Vestibular evoked myogenic potentials at baseline
  • Diagnostic Test: Audiogram at baseline
  • Diagnostic Test: Measuring Orthostatic Blood Pressure at baseline
  • Diagnostic Test: cold pressor test at baseline
  • Diagnostic Test: vitamin D plasma levels one year after recruitment
  • Diagnostic Test: vitamin D plasma levels two years after recruitment
  • Diagnostic Test: Dual-energy X-ray absorptiometry one year after recruitment
  • Diagnostic Test: Dual-energy X-ray absorptiometry two years after recruitment
  • Diagnostic Test: cervical Vestibular evoked myogenic potentials one year after recruitment
  • Diagnostic Test: cervical Vestibular evoked myogenic potentials two years after recruitment
  • Diagnostic Test: Audiogram one year after recruitment
  • Diagnostic Test: Audiogram two years after recruitment
  • Diagnostic Test: Measuring Orthostatic Blood Pressure one year after recruitment
  • Diagnostic Test: Measuring Orthostatic Blood Pressure two years after recruitment
  • Diagnostic Test: cold pressor test one year after recruitment
  • Diagnostic Test: cold pressor test two years after recruitment
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Menier's Disease - Bone Density Study
Anticipated Study Start Date :
Oct 1, 2022
Anticipated Primary Completion Date :
Jun 30, 2028
Anticipated Study Completion Date :
Dec 31, 2028

Arms and Interventions

Arm Intervention/Treatment
Other: Controls

Healthy controls with no known vestibular disease

Diagnostic Test: vitamin D plasma levels baseline
Measuring vitamin D plasma levels at baseline

Diagnostic Test: Dual-energy X-ray absorptiometry at baseline
Measuring T-score and Z-score of the femur and lumbar spine at baseline
Other Names:
  • DEXA
  • Diagnostic Test: Measuring Orthostatic Blood Pressure at baseline
    blood pressure will be measure two minutes after lying supine and repeated 3 minutes after standing. A drop of at least 20mmHg systolic pressure or at least 10mmHg diastolic blood pressure is considered a positive test
    Other Names:
  • Orthostatic Hypotension
  • Diagnostic Test: cold pressor test at baseline
    The cold pressor test is an indicator for sympathetic system function. A rise of at least 15mmHg of systolic pressure after putting the subject's hand in cold water (4 deg Celsius) is indicative of normal sympathetic function.

    Experimental: Definite Meniere's disease

    Patients with Definite Meniere's disease

    Diagnostic Test: vitamin D plasma levels baseline
    Measuring vitamin D plasma levels at baseline

    Diagnostic Test: Dual-energy X-ray absorptiometry at baseline
    Measuring T-score and Z-score of the femur and lumbar spine at baseline
    Other Names:
  • DEXA
  • Diagnostic Test: cervical Vestibular evoked myogenic potentials at baseline
    cVEMP is a vestibular test for saccular function, an otolith organ in the inner ear. the electrical response of the stermocledomastoid muscle to saccular stimulation is measured via two distinct waves - P13 and N23. the latency, amplitude and peak to peak amplitude will be measured.
    Other Names:
  • cVEMP
  • Diagnostic Test: Audiogram at baseline
    hearing measurement will be performed. Hearing level in dB will be performed in the 250-8,000 Hz frequency. The test includes Speech reception threshold and word recognition score.
    Other Names:
  • Hearing test
  • Diagnostic Test: Measuring Orthostatic Blood Pressure at baseline
    blood pressure will be measure two minutes after lying supine and repeated 3 minutes after standing. A drop of at least 20mmHg systolic pressure or at least 10mmHg diastolic blood pressure is considered a positive test
    Other Names:
  • Orthostatic Hypotension
  • Diagnostic Test: cold pressor test at baseline
    The cold pressor test is an indicator for sympathetic system function. A rise of at least 15mmHg of systolic pressure after putting the subject's hand in cold water (4 deg Celsius) is indicative of normal sympathetic function.

    Diagnostic Test: vitamin D plasma levels one year after recruitment
    Measuring vitamin D plasma levels one year after recruitment

    Diagnostic Test: vitamin D plasma levels two years after recruitment
    Measuring vitamin D plasma levels two years after recruitment

    Diagnostic Test: Dual-energy X-ray absorptiometry one year after recruitment
    Measuring T-score and Z-score of the femur and lumbar spine one year after recruitment
    Other Names:
  • DEXA
  • Diagnostic Test: Dual-energy X-ray absorptiometry two years after recruitment
    Measuring T-score and Z-score of the femur and lumbar spine two years after recruitment

    Diagnostic Test: cervical Vestibular evoked myogenic potentials one year after recruitment
    cVEMP is a vestibular test for saccular function, an otolith organ in the inner ear. the electrical response of the stermocledomastoid muscle to saccular stimulation is measured via two distinct waves - P13 and N23. the latency, amplitude and peak to peak amplitude will be measured one year after recruitment
    Other Names:
  • cVEMP
  • Diagnostic Test: cervical Vestibular evoked myogenic potentials two years after recruitment
    cVEMP is a vestibular test for saccular function, an otolith organ in the inner ear. the electrical response of the stermocledomastoid muscle to saccular stimulation is measured via two distinct waves - P13 and N23. the latency, amplitude and peak to peak amplitude will be measured two years after recruitment
    Other Names:
  • cVEMP
  • Diagnostic Test: Audiogram one year after recruitment
    hearing measurement will be performed. Hearing level in dB will be performed in the 250-8,000 Hz frequency. The test includes Speech reception threshold and word recognition score performed one year after recruitment
    Other Names:
  • Hearing test
  • Diagnostic Test: Audiogram two years after recruitment
    hearing measurement will be performed. Hearing level in dB will be performed in the 250-8,000 Hz frequency. The test includes Speech reception threshold and word recognition score performed two years after recruitment
    Other Names:
  • Hearing test
  • Diagnostic Test: Measuring Orthostatic Blood Pressure one year after recruitment
    blood pressure will be measure two minutes after lying supine and repeated 3 minutes after standing. A drop of at least 20mmHg systolic pressure or at least 10mmHg diastolic blood pressure is considered a positive test. The test will be performed one year after recruitment
    Other Names:
  • Ortostatic hypostension
  • Diagnostic Test: Measuring Orthostatic Blood Pressure two years after recruitment
    blood pressure will be measure two minutes after lying supine and repeated 3 minutes after standing. A drop of at least 20mmHg systolic pressure or at least 10mmHg diastolic blood pressure is considered a positive test. The test will be performed two year after recruitment.
    Other Names:
  • Ostostatic hypotension
  • Diagnostic Test: cold pressor test one year after recruitment
    The cold pressor test is an indicator for sympathetic system function. A rise of at least 15mmHg of systolic pressure after putting the subject's hand in cold water (4 deg Celsius) is indicative of normal sympathetic function. The test will be performed one year after recruitment.

    Diagnostic Test: cold pressor test two years after recruitment
    The cold pressor test is an indicator for sympathetic system function. A rise of at least 15mmHg of systolic pressure after putting the subject's hand in cold water (4 deg Celsius) is indicative of normal sympathetic function. The test will be performed two years after recruitment.

    Outcome Measures

    Primary Outcome Measures

    1. Vitamin D plasma levels [baseline]

      Vitamin D plasma levels

    2. Vitamin D plasma levels [one year follow up]

      Vitamin D plasma levels

    3. Vitamin D plasma levels [two years follow-up]

      Vitamin D plasma levels

    4. Z-score and T-score of femur and lumbur spine [baseline]

      DEXA exam - bone density. higher score means better resuls. osteopenia is defined as <-1 score , osteoporosis is defined as <-2.5 score

    5. Z-score and T-score of femur and lumbur spine [one year follow up]

      DEXA exam - bone density. higher score means better resuls. osteopenia is defined as <-1 score , osteoporosis is defined as <-2.5 score

    6. Z-score and T-score of femur and lumbur spine [two years follow-up]

      DEXA exam - bone density. higher score means better resuls. osteopenia is defined as <-1 score , osteoporosis is defined as <-2.5 score

    Secondary Outcome Measures

    1. positive ortostatic hypotension [baseline]

      drop of 20mmHg systolic blood pressure or drop of 10mmHG diastolic blood pressure after 3 minutes of standing up. all other results - negetive

    2. positive ortostatic hypotension [one year follow up]

      drop of 20mmHg systolic blood pressure or drop of 10mmHG diastolic blood pressure after 3 minutes of standing up. all other results - negetive

    3. positive ortostatic hypotension [Two years follow-up]

      drop of 20mmHg systolic blood pressure or drop of 10mmHG diastolic blood pressure after 3 minutes of standing up. all other results - negetive

    4. cold pressure - autonomous sympatetic nervous system function - normal vs, inadequete [baseline]

      a rise of less then 15mmHg after the test is considered inadequete function, more then 15hhHg - normal function

    5. cold pressure - autonomous sympatetic nervous system function - normal vs, inadequete [one year follow up]

      a rise of less then 15mmHg after the test is considered inadequete function, more then 15hhHg - normal function

    6. cold pressure - autonomous sympatetic nervous system function - normal vs, inadequete [two years follow-up]

      a rise of less then 15mmHg after the test is considered inadequete function, more then 15hhHg - normal function

    7. ampitude, latency and peak to peak amplitude of the P13 and N23 waves in the cVEMP test [baseline]

      cervical vestibular evoked myogenic potential exam

    8. ampitude, latency and peak to peak amplitude of the P13 and N23 waves in the cVEMP test [one year follow up]

      cervical vestibular evoked myogenic potential exam

    9. ampitude, latency and peak to peak amplitude of the P13 and N23 waves in the cVEMP test [two years follow-up]

      cervical vestibular evoked myogenic potential exam

    10. Hearing level (dB), SRT in dB , descrimination in (%) in the audiology exam [baseline]

      audiology exam

    11. Hearing level (dB), SRT in dB , descrimination in (%) in the audiology exam [one year follow up]

      audiology exam

    12. Hearing level (dB), SRT in dB , descrimination in (%) in the audiology exam [two years follow-up]

      audiology exam

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Definite Meniere's disease
    Exclusion Criteria:
    • hyperthyroidism

    • hyperparathyroidism

    • acromegaly

    • hypogonadism

    • diabetes melitus

    • chronic renal failure

    • alcoholism

    • cushing syndrome

    • rheumatoid arthritis

    • systemic lupus erythematosus

    • ankylosing spondylitis

    • inflammatory bowel disease

    • obstructive lung disease

    • sarcoidosis

    • amyloidosis

    • celiac disease.

    • chronic treatment with bisphosphonates

    • chronic treatment with glucocorticoids

    • chronic treatment with androgen deprivation therapy

    • chronic treatment with gonadotropin releasing hormone agonist chronic treatment with aromatase inhibitor chronic treatment with loop diuretics chronic treatment with proton pump inhibitors chronic treatment with anti-seizure drugs chronic treatment with warfarin chronic treatment with SSRI chronic treatment with alpha or beta-blockers

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • HaEmek Medical Center, Israel

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Paker Miki, Attending physician, Otolaryngology head and neck surgery department, HaEmek Medical Center, Israel
    ClinicalTrials.gov Identifier:
    NCT05322538
    Other Study ID Numbers:
    • EMC-22-0031
    First Posted:
    Apr 12, 2022
    Last Update Posted:
    Aug 3, 2022
    Last Verified:
    Aug 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 3, 2022